Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer
在转移性结直肠癌中，每 4 周一次的贝伐单抗与每 2 周一次的贝伐单抗联合每两周一次的 FOLFIRI 方案疗效相当。
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-012-1264-5
Yildiz, Ramazan; Benekli, Mustafa; Ozkan, Metin; Alkis, Necati; Berk, Veli; Kaplan, Mehmet Ali; Ciltas, Aydin; Karaca, Halit; Durnali, Ayse Gok; Coskun, Ugur; Dikilitas, Mustafa; Sevinc, Alper; Dane, Faysal; Yetisyigit, Tarkan; Dogu, Gamze Gokoz; Buyukberber, Suleyman
